To test this, RNAseq data for tumors from The Cancer Genome Atlas (TCGA) with mutations analogous to those found in the CD19 negative lymphomas (region (R) 1 highlighted in Fig. 2a) were compared with mutations found in CD19 positive lymphomas (R2 highlighted in Fig. 2a). Here, CD19 is linked to lymphoma.